Trials / Completed
CompletedNCT00216775
Comparative Trial of Standard Versus Low-dose Peg-Interferon Plus Ribavirin in the Treatment of Chronic Hepatitis C
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 50 (actual)
- Sponsor
- Kyoto University · Academic / Other
- Sex
- All
- Age
- 20 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the efficacy and safety of low-dose interferon-alfa-2b plus ribavirin compared to the standard-dose of the same combination in patients with chronic hepatitis C.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | interferon-alfa-2b and ribavirin |
Timeline
- Start date
- 2004-12-01
- Primary completion
- 2008-05-01
- Completion
- 2008-05-01
- First posted
- 2005-09-22
- Last updated
- 2015-09-02
Locations
4 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT00216775. Inclusion in this directory is not an endorsement.